Drug intelligence / Profile preview

SWAP-70 short hairpin RNA

Development stage
Preclinical
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intraperitoneal
01

Overview

SWAP-70 short hairpin RNA is an RNA interference (RNAi) based therapeutic agent designed to silence the expression of the Switch-associated protein 70 (SWAP-70). SWAP-70 is a multifunctional signal transduction molecule and guanine nucleotide exchange factor (GEF) primarily expressed in B cells, where it regulates critical processes such as polarization, directed migration, and adhesion to endothelial cells. In the context of autoimmune diseases like Multiple Sclerosis (MS), SWAP-70 is implicated in the pathogenic activation and homing of B cells to the central nervous system. By utilizing shRNA to knock down SWAP-70 levels, this therapy aims to modulate B-cell-mediated immune responses and reduce neuroinflammation. Preclinical research using the experimental autoimmune encephalomyelitis (EAE) model has demonstrated that acquired inhibition of SWAP-70 can alter immune cell subsets and ameliorate disease progression.

Other names
SWAP-70 shRNASWAP70 shRNASWAP 70 shRNAshSWAP-70shSWAP70shSWAP 70shRNA targeting SWAP-70
02

Targets

SWAP70 (Switch-associated protein 70)

Beyond the preview

Go deeper on SWAP-70 short hairpin RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SWAP-70 short hairpin RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call